Toward a solid-phase nucleic acid hybridization assay within microfluidic channels using immobilized quantum dots as donors in fluorescence resonance energy transfer

Affinity biosensors developed with quantum dots in microfluidic systems

Quantum dots (QDs) are synthetic semiconductor nanocrystals with unique optical and electronic properties due to their size (2-10 nm) such as high molar absorption coefficient (10-100 times higher than organic dyes), resistance to chemical degradation, and unique optoelectronic properties due to quantum confinement (high quantum yield, emission color change with size). Compared to organic fluorophores, the narrower emission band and wider absorption bands of QDs offer great advantages in cell imaging and biosensor applications. The optoelectronic features of QDs have prompted their intensive use in bioanalytical, biophysical, and biomedical research. As the nanomaterials have been integrated into microfluidic systems, microfluidic technology has accelerated the adaptation of nanomaterials to clinical evaluation together with the advantages such as being more economical, more reproducible, and more susceptible to modification and integration with other technologies. Microfluidic systems serve an important role by being a platform in which QDs are integrated for biosensing applications. As we combine the advantages of QDs and microfluidic technology for biosensing technology, QD-based biosensor integrated with microfluidic systems can be used as an advanced and versatile diagnostic technology in case of pandemic. Specifically, there is an urgent necessity to have reliable and fast detection systems for COVID-19 virus. In this review, affinity-based biosensing mechanisms which are developed with QDs are examined in the domain of microfluidic approach. The combination of microfluidic technology and QD-based affinity biosensors are presented with examples in order to develop a better technological framework of diagnostic for COVID-19 virus.

Inorganic Nanoparticles as Donors in Resonance Energy Transfer for Solid-Phase Bioassays and Biosensors

Bioassays for the rapid detection and quantification of specific nucleic acids, proteins, and peptides are fundamental tools in many clinical settings. Traditional optical emission methods have focused on the use of molecular dyes as labels to track selective binding interactions and as probes that are sensitive to environmental changes. Such dyes can offer good detection limits based on brightness but typically have broad emission bands and suffer from time-dependent photobleaching. Inorganic nanoparticles such as quantum dots and upconversion nanoparticles are photostable over prolonged exposure to excitation radiation and tend to offer narrow emission bands, providing a greater opportunity for multiwavelength multiplexing. Importantly, in contrast to molecular dyes, nanoparticles offer substantial surface area and can serve as platforms to carry a large number of conjugated molecules. The surface chemistry of inorganic nanoparticles offers both challenges and opportunities for the control of solubility and functionality for selective molecular interactions by the assembly of coatings through coordination chemistry. This report reviews advances in the compositional design and methods of conjugation of inorganic quantum dots and upconversion nanoparticles and the assembly of combinations of nanoparticles to achieve energy exchange. Our interest is the exploration of configurations where the modified nanoparticles can be immobilized to solid substrates for the development of bioassays and biosensors that operate by resonance energy transfer (RET).

Active bioparticle manipulation in microfluidic systems

The motion of bioparticles in a microfluidic environment can be actively controlled using several tuneable mechanisms, including hydrodynamic, electrophoresis, dielectrophoresis, magnetophoresis, acoustophoresis, thermophoresis and optical forces.

Multifunctional quantum dots-based cancer diagnostics and stem cell therapeutics for regenerative medicine

A field of recent diagnostics and therapeutics has been advanced with quantum dots (QDs). QDs have developed into new formats of biomolecular sensing to push the limits of detection in biology and medicine. QDs can be also utilized as bio-probes or labels for biological imaging of living cells and tissues. More recently, QDs has been demonstrated to construct a multifunctional nanoplatform, where the QDs serve not only as an imaging agent, but also a nanoscaffold for diagnostic and therapeutic modalities. This review highlights the promising applications of multi-functionalized QDs as advanced nanosensors for diagnosing cancer and as innovative fluorescence probes for in vitro or in vivo stem cell imaging in regenerative medicine.

Solid-phase supports for the in situ assembly of quantum dot-FRET hybridization assays in channel microfluidics

Semiconductor quantum dots (QDs) have long served as integral components in signal transduction modalities such as Förster resonance energy transfer (FRET). The majority of bioanalytical methods using QDs for FRET-based techniques simply monitor binding-induced conformational changes. In more recent work, QDs have been incorporated into solid-phase support systems, such as microfluidic chips, to serve as physical platforms in the development of functional biosensors and bioprobes. Herein, we describe a simple strategy for the transduction of nucleic acid hybridization that combines a novel design method based on FRET with an electrokinetically controlled microfluidic technology, and that offers further potential for amelioration of sample-handling issues and for simplification of dynamic stringency control.

Quantum dot and gold nanoparticle immobilization for biosensing applications using multidentate imidazole surface ligands

A facile approach for modification of solid substrates with multidentate imidazole ligands was developed for immobilization of high densities of quantum dots (QDs) that were capped with hydrophilic thiol-based ligands, and for immobilization of noble metal nanoparticles. Imidazole polymer was synthesized using poly(acrylic acid) as a backbone, and grafted on amine functionalized substrate in a two-step approach. The polymer-modified surface was characterized using ellipsometry, water contact angle, and X-ray photoelectron spectroscopy. Fluorescence spectroscopy and scanning electron microscopy were used to evaluate nanoparticle immobilization. Homogeneous, high density (ca. 5 × 10(11) cm(-2)) QD films formed via self-assembly were obtained within 4-6 h. Similarly, the imidazole polymer was also shown to be effective for immobilization of gold nanoparticles as a uniform film. By making use of the pH-sensitive affinity of the imidazole rings to zinc on the surface of QDs, it was possible to achieve regeneration of functional ligands suitable for subsequent immobilization of new QDs. Immobilized QDs were used as a platform for bioconjugation with oligonucleotides and peptides. The transduction of nucleic acid hybridization and enzyme activity using QDs as energy donors in interfacial fluorescence resonance energy transfer (FRET) indicated that the immobilization strategy preserved the functional properties of the QDs. The multidentate imidazole ligands used for QD immobilization offer the highest denticity of binding in comparison to the currently available approaches without compromise in their optical properties and ability to interact with biomolecules in solution.

Application of quantum dots as analytical tools in automated chemical analysis: a review

Colloidal semiconductor nanocrystals or quantum dots (QDs) are one of the most relevant developments in the fast-growing world of nanotechnology. Initially proposed as luminescent biological labels, they are finding new important fields of application in analytical chemistry, where their photoluminescent properties have been exploited in environmental monitoring, pharmaceutical and clinical analysis and food quality control. Despite the enormous variety of applications that have been developed, the automation of QDs-based analytical methodologies by resorting to automation tools such as continuous flow analysis and related techniques, which would allow to take advantage of particular features of the nanocrystals such as the versatile surface chemistry and ligand binding ability, the aptitude to generate reactive species, the possibility of encapsulation in different materials while retaining native luminescence providing the means for the implementation of renewable chemosensors or even the utilisation of more drastic and even stability impairing reaction conditions, is hitherto very limited. In this review, we provide insights into the analytical potential of quantum dots focusing on prospects of their utilisation in automated flow-based and flow-related approaches and the future outlook of QDs applications in chemical analysis.

Sensitive and rapid quantification of C-reactive protein using quantum dot-labeled microplate immunoassay

Background

High-sensitivity C-reactive protein (hs-CRP) assay is of great clinical importance in predicting risks associated with coronary heart disease. Existing hs-CRP assays either require complex operation or have low throughput and cannot be routinely implemented in rural settings due to limited laboratory resources.

Methods

We developed a novel hs-CRP assay capable of simultaneously quantifying over 90 clinical samples by using quantum dots-labeled immunoassay within a standard 96-well microplate. The specificity of the assay was enhanced by adopting two monoclonal antibodies (mAbs) that target distinct hs-CRP epitopes, serving as the coating antibody and the detection antibody, respectively. In the presence of hs-CRP antigen, the fluorescence intensity of the mAb-Ag-mAb sandwich complex captured on the microplate can be read out using a microplate reader.

Results

The proposed hs-CRP assay provides a wide analytical range of 0.001-100 mg/L with a detection limit of 0.06 (0.19) μg/L within 1.5 h. The accuracy of the proposed assay has been confirmed for low coefficient of variations (CVs), 2.27% (intra-assay) and 8.52% (inter-assay), together with recoveries of 96.7-104.2%. Bland-Altman plots of 104 clinical samples exhibited good consistency among the proposed assay, commercial high-sensitivity ELISA, and nephelometry, indicating the prospects of the newly developed hs-CRP assay as an alternative to existing hs-CRP assays.

Conclusion

The developed assay meets the needs of the rapid, sensitive and high-throughput determination of hs-CRP levels within a short time using minimal resources. In addition, the developed assay can also be used to detect and quantify other diagnostic biomarkers by immobilizing specific monoclonal antibodies.

Biosensing with quantum dots: a microfluidic approach

Semiconductor quantum dots (QDs) have served as the basis for signal development in a variety of biosensing technologies and in applications using bioprobes. The use of QDs as physical platforms to develop biosensors and bioprobes has attracted considerable interest. This is largely due to the unique optical properties of QDs that make them excellent choices as donors in fluorescence resonance energy transfer (FRET) and well suited for optical multiplexing. The large majority of QD-based bioprobe and biosensing technologies that have been described operate in bulk solution environments, where selective binding events at the surface of QDs are often associated with relatively long periods to reach a steady-state signal. An alternative approach to the design of biosensor architectures may be provided by a microfluidic system (MFS). A MFS is able to integrate chemical and biological processes into a single platform and allows for manipulation of flow conditions to achieve, by sample transport and mixing, reaction rates that are not entirely diffusion controlled. Integrating assays in a MFS provides numerous additional advantages, which include the use of very small amounts of reagents and samples, possible sample processing before detection, ultra-high sensitivity, high throughput, short analysis time, and in situ monitoring. Herein, a comprehensive review is provided that addresses the key concepts and applications of QD-based microfluidic biosensors with an added emphasis on how this combination of technologies provides for innovations in bioassay designs. Examples from the literature are used to highlight the many advantages of biosensing in a MFS and illustrate the versatility that such a platform offers in the design strategy.